Resmed SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 29, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Other events · Financial statements and exhibits
AI summary, unreviewedResMed Q1 fiscal 2027 non-GAAP EPS $2.91 beats $2.67 consensus on $1.415 billion revenue; full-year guidance reiterated
8-KSept. 1, 2026, 4:30 p.m. ETView on SEC.gov
Other events
8-KAug. 17, 2026, 4:30 p.m. ETView on SEC.gov
Change in certifying accountant · Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 6, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Other events · Financial statements and exhibits